Research on modified mRNA influenza vaccines has shown promising results in preclinical studies, with some vaccines demonstrating potent protection against seasonal influenza viruses. These vaccines have been found to elicit strong humoral and cellular immunity, and may also reduce the transmission and pathogenicity of certain influenza viruses. The studies suggest that mRNA vaccine platforms may be effective in preventing and mitigating influenza infection.